TELA Bio Inc [TELA] stock is trading at $1.27, up 4.10%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TELA shares have gain 2.42% over the last week, with a monthly amount drifted -45.73%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
TELA Bio Inc [NASDAQ: TELA] stock has seen the most recent analyst activity on March 21, 2025, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $2 from $5. Previously, Lake Street started tracking the stock with Buy rating on May 31, 2022, and set its price target to $17. On December 03, 2019, Piper Jaffray initiated with a Overweight rating. JMP Securities started tracking the stock assigning a Mkt Outperform rating. Jefferies initiated its recommendation with a Buy.
TELA Bio Inc [TELA] stock has fluctuated between $1.14 and $6.50 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. TELA Bio Inc [NASDAQ: TELA] shares were valued at $1.27 at the most recent close of the market. An investor can expect a potential return of 529.92% based on the average TELA price forecast.
Analyzing the TELA fundamentals
TELA Bio Inc [NASDAQ:TELA] reported sales of 69.30M for the trailing twelve months, which represents a growth of 3.83%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.6%, Pretax Profit Margin comes in at -0.55%, and Net Profit Margin reading is -0.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -3.84 and Total Capital is -0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1933 points at the first support level, and at 1.1167 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3333, and for the 2nd resistance point, it is at 1.3967.
Ratios To Look Out For
For context, TELA Bio Inc’s Current Ratio is 5.01. As well, the Quick Ratio is 4.19, while the Cash Ratio is 3.38. Considering the valuation of this stock, the price to sales ratio is 0.72, the price to book ratio is 1.76.
Transactions by insiders
Recent insider trading involved Cuca Roberto, COO and CFO, that happened on Oct 24 ’24 when 64444.0 shares were purchased. Chief Technology Officer, Talmo Paul completed a deal on Oct 24 ’24 to buy 22222.0 shares. Meanwhile, Chief Executive Officer KOBLISH ANTONY bought 88888.0 shares on Oct 24 ’24.
